AbbVie formely Abbott, a global research and development-based biopharmaceutical company, has announced an expansion of its manufacturing facility in Sligo to support the growth of its Oncology pipeline. The $139 million (€113.6 million) investment in new sterile manufacturing technology at the Ballytivnan site will help deliver promising treatments for cancers with significant unmet medical needs.
The expansion will create approximately 100 new jobs over the course of 3 years in a variety of technical and manufacturing positions. The project is supported by the Government through IDA Ireland.
Welcoming the announcement by AbbVie, Minister for Business, Enterprise and Innovation, Heather Humphreys TD, said "The pharma industry is a jewel in the crown of Ireland's new high-tech industries, with huge levels of investment and quality jobs being created. Government is keen that dynamic pharma companies like AbbVie can expand their operations as they will broaden the reach of the industry here and generate new opportunities.
"This is a major investment which will bring 100 new quality jobs and it has the added benefit of being located in the North West Region, which builds on the government's commitment to regional development as part of the Action Plan for Jobs process. "This expansion of its operation in Sligo is a great vote of confidence in what that region has to offer.”
“This investment demonstrates AbbVie’s commitment to Ireland, and the laser focus of our team in Sligo on making a remarkable impact on patients’ lives,” said Joe Kumor, Site Director, Ballytivnan. “We are proud to be recognised for our high performance over the years, and are excited to have been chosen to help accelerate AbbVie’s oncology pipeline.”70-year commitment
CEO of IDA Ireland, Martin Shanahan said: “The pharma sector is one of our fastest growing sectors and makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports. This expansion by AbbVie is great news. It builds on their more than 70-year commitment to Ireland and is a tremendous vote of confidence in the capability of the workforce in Sligo and the wider North West Region. Securing regional investments is a key part of IDA’s strategy. I wish the company continued success.”
Fine Gael T.D. for Sligo-Leitrim, Tony Mc Loughlin stated, “I have been raising the problem with the lack of job creation in my constituency at every opportunity I have had in the Dáil since being elected and I am absolutely delighted with this announcement.
“I am delighted to see this business is going from strength to strength in Sligo and today’s announcement is a further boost to Sligo and its local economy”.
“This announcement by AbbVie is a strong endorsement of the skilled workforce, facilities and services available in the Sligo area and proof that our town can continue to attract investment and jobs going forward.
Fianna Fáil TD for Sligo-Leitrim Eamon Scanlon commented, “This jobs announcement is a vote of confidence in the workforce in Sligo and the greater North-West region and is particularly welcome following a series of job losses and plant closures in recent times.
“Abbvie, or Abbot as it was formerly known, has been a major employer in the area for decades. The expansion of the Ballytivnan site comes at a very welcome time and will provide a huge boost to the local economy. I want to pay tribute to the IDA, which played a fundamental part in securing these new jobs, which will be a combination of technical and manufacturing.
“Abbvie has been a success story in Sligo but we need to ensure more investment in the region through a strategic economic and social plan. The current two tier economy, as pioneered by this Fine Gael led government, has seen the North West region left behind. This trend needs to be reversed and I will be keeping pressure on local government TDs to start delivering for this area”.